CD47 overexpression
|
Triple Negative Breast Cancer
|
CD47 overexpression
|
Triple Negative Breast Cancer
|
VT1021 Sensitive: C3 – Early Trials
|
VT1021 Sensitive: C3 – Early Trials
|
CD47 overexpression
|
GBM
|
CD47 overexpression
|
GBM
|
VT1021 Sensitive: C3 – Early Trials
|
VT1021 Sensitive: C3 – Early Trials
|
CD47 overexpression
|
Ovarian Cancer
|
CD47 overexpression
|
Ovarian Cancer
|
VT1021 Sensitive: C3 – Early Trials
|
VT1021 Sensitive: C3 – Early Trials
|
CD47 overexpression
|
Solid Tumor
|
CD47 overexpression
|
Solid Tumor
|
VT1021 Sensitive: D – Preclinical
|
VT1021 Sensitive: D – Preclinical
|